SLC7A11 and adrenal cortex carcinoma: Through their bioinformatics approaches, Lin et al. (2022) concluded that SLC7A11 was found to be highly expressed in the 20 types of cancer and the up-regulated expression of SLC7A11 was related to poor prognosis in a variety of cancer including, including adrenocortical carcinoma, cervical squamous cell carcinoma and endocardial adenocarcinoma, and so on (Lin et al., 2022).